loading
전일 마감가:
$1.17
열려 있는:
$1.16
하루 거래량:
153.36K
Relative Volume:
0.03
시가총액:
$5.16M
수익:
-
순이익/손실:
$-11.66M
주가수익비율:
-0.1326
EPS:
-8.156
순현금흐름:
$-11.09M
1주 성능:
-17.05%
1개월 성능:
-18.94%
6개월 성능:
-65.26%
1년 성능:
-82.85%
1일 변동 폭
Value
$1.05
$1.16
1주일 범위
Value
$1.05
$1.32
52주 변동 폭
Value
$1.05
$9.79

Phio Pharmaceuticals Corp Stock (PHIO) Company Profile

Name
명칭
Phio Pharmaceuticals Corp
Name
전화
(508) 767-3861
Name
주소
11 APEX DRIVE, SUITE 300A, MARLBOROUGH, MA
Name
직원
9
Name
트위터
@phio_pharma
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
PHIO's Discussions on Twitter

PHIO을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
PHIO
Phio Pharmaceuticals Corp
1.0816 5.16M 0 -11.66M -11.09M -8.156
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
479.27 125.40B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
581.69 65.79B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
556.00 35.18B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
240.00 32.67B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
240.24 26.46B 3.81B -644.79M -669.77M -6.24

Phio Pharmaceuticals Corp Stock (PHIO) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2020-08-05 개시 H.C. Wainwright Buy

Phio Pharmaceuticals Corp 주식(PHIO)의 최신 뉴스

pulisher
Apr 03, 2025

Groundbreaking Cancer Treatment Data: Phio's Dual Immunotherapy Candidates Show Promise - Stock Titan

Apr 03, 2025
pulisher
Apr 01, 2025

Phio stock hits 52-week low at $1.22 amid sharp annual decline - Investing.com

Apr 01, 2025
pulisher
Apr 01, 2025

Phio stock hits 52-week low at $1.22 amid sharp annual decline By Investing.com - Investing.com South Africa

Apr 01, 2025
pulisher
Apr 01, 2025

Phio Pharmaceuticals Corp reports results for the quarter ended December 31Earnings Summary - TradingView

Apr 01, 2025
pulisher
Apr 01, 2025

Virtu Financial LLC Makes New Investment in Phio Pharmaceuticals Corp. (NASDAQ:PHIO) - Defense World

Apr 01, 2025
pulisher
Mar 31, 2025

Phio Pharmaceuticals Reports 2024 Year End Financial Results and Provides Business Update - TradingView

Mar 31, 2025
pulisher
Mar 31, 2025

Phio's Cancer Drug Shows Complete Response as Company Slashes Losses by 33% - Stock Titan

Mar 31, 2025
pulisher
Mar 31, 2025

Phio Pharmaceuticals (PHIO) Expected to Announce Earnings on Monday - Defense World

Mar 31, 2025
pulisher
Mar 19, 2025

PHIO PHARMACEUTICALS CORP- The GF Score's 5 Key Aspects of Analysis - GuruFocus.com

Mar 19, 2025
pulisher
Mar 12, 2025

PHIOPhio Pharmaceuticals Corp Latest Stock News & Market Updates - Stock Titan

Mar 12, 2025
pulisher
Mar 10, 2025

American Academy of Dermatology Awards Podium Presentation to Phio Pharmaceutical's Clinical Research at 2025 Annual Meeting - Quantisnow

Mar 10, 2025
pulisher
Mar 10, 2025

Phio Reports 50% Complete Response Rate in Skin Cancer Trial - StockTitan

Mar 10, 2025
pulisher
Mar 05, 2025

Phio Pharmaceuticals Announces Completion of Enrollment in Third Safety Cohort in PH-762 Phase 1b Dose-Escalation Study - Newsfile

Mar 05, 2025
pulisher
Mar 04, 2025

PHIO stock touches 52-week low at $1.25 amid sharp annual decline - Investing.com Australia

Mar 04, 2025
pulisher
Feb 28, 2025

Phio Pharma Stock Quadruples On Positive Data From Cancer Treatment Trial: Retail’s Elated - MSN

Feb 28, 2025
pulisher
Feb 26, 2025

Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series - Newsfile

Feb 26, 2025
pulisher
Feb 26, 2025

Can Phio's Novel siRNA Cancer Technology Impress Investors at Upcoming Roadshow? - StockTitan

Feb 26, 2025
pulisher
Feb 25, 2025

PHIO stock touches 52-week low at $1.48 amid market challenges - Investing.com

Feb 25, 2025
pulisher
Feb 25, 2025

PHIO stock touches 52-week low at $1.48 amid market challenges By Investing.com - Investing.com South Africa

Feb 25, 2025
pulisher
Feb 22, 2025

Brokers Offer Predictions for PHIO FY2024 Earnings - Defense World

Feb 22, 2025
pulisher
Feb 22, 2025

Comparing Tharimmune (NASDAQ:THAR) and Phio Pharmaceuticals (NASDAQ:PHIO) - Defense World

Feb 22, 2025
pulisher
Feb 20, 2025

Phio Pharmaceuticals Appoints David Deming to Board - TipRanks

Feb 20, 2025
pulisher
Feb 20, 2025

Phio Pharmaceuticals expands board with new director By Investing.com - Investing.com Nigeria

Feb 20, 2025
pulisher
Feb 20, 2025

Phio Pharmaceuticals Corp. Appoints David H. Deming to Board of Directors -February 20, 2025 at 09:54 am EST - Marketscreener.com

Feb 20, 2025
pulisher
Feb 20, 2025

H.C. Wainwright maintains Buy rating, $4 target on Phio Pharma stock - Investing.com

Feb 20, 2025
pulisher
Feb 20, 2025

Phio Pharmaceuticals expands board with new director - Investing.com

Feb 20, 2025
pulisher
Feb 20, 2025

Phio Pharmaceuticals Announces Appointment of David H. Deming to Board of Directors - Newsfile

Feb 20, 2025
pulisher
Feb 20, 2025

Phio Pharmaceuticals (NASDAQ:PHIO) Given “Buy” Rating at HC Wainwright - Defense World

Feb 20, 2025
pulisher
Feb 18, 2025

PHIO Stock: The Biotech Breakthrough You Can't Ignore! Is This the Future of Immunotherapy? - Elblog.pl

Feb 18, 2025
pulisher
Feb 18, 2025

Reviewing BridgeBio Pharma (NASDAQ:BBIO) & Phio Pharmaceuticals (NASDAQ:PHIO) - Defense World

Feb 18, 2025
pulisher
Feb 11, 2025

Phio Pharmaceuticals (NASDAQ:PHIO) Shares Down 5.8% – Should You Sell? - Defense World

Feb 11, 2025
pulisher
Feb 07, 2025

Phio Pharma (NASDAQ:PHIO) Stock Quotes, Forecast and News Summary - Benzinga

Feb 07, 2025
pulisher
Feb 03, 2025

Inside Phio's Revolutionary siRNA Cancer Treatment: CEO Reveals Clinical Progress - StockTitan

Feb 03, 2025
pulisher
Jan 25, 2025

Revolutionary Cancer Treatment or Environmental Savior? - Elblog.pl

Jan 25, 2025
pulisher
Jan 23, 2025

Phio Pharmaceuticals (PHIO) Stock Price, News & Analysis - MarketBeat

Jan 23, 2025
pulisher
Jan 22, 2025

Phio Pharmaceuticals CEO to Present Breakthrough Cancer Treatment at Renmark Virtual Roadshow - StockTitan

Jan 22, 2025
pulisher
Jan 21, 2025

Phio Pharmaceuticals Announces Closing of $1.83 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - Newsfile

Jan 21, 2025
pulisher
Jan 17, 2025

We Asked Retail What's Next For Phio Pharma After Monday's Blistering Rally: Most See More Room To Run - MSN

Jan 17, 2025
pulisher
Jan 16, 2025

Phio Pharmaceuticals Raises $1.83M in Direct Offering with Warrant Coverage at $3.00/Share - StockTitan

Jan 16, 2025
pulisher
Jan 16, 2025

Stock market news: Phio Pharmaceuticals +50.19%, DatChat +46.01% among top gainers during mid day trading - Business Upturn

Jan 16, 2025
pulisher
Jan 16, 2025

Phio Pharmaceuticals Announces $1.83 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - Financial Content

Jan 16, 2025
pulisher
Jan 15, 2025

Biotech Alert: Searches spiking for these stocks today - TipRanks

Jan 15, 2025
pulisher
Jan 15, 2025

Stock market today: Phio Pharmaceuticals -20.76%, Soligenix -20.15% among biggest losers in early trading - Business Upturn

Jan 15, 2025
pulisher
Jan 15, 2025

Phio Pharmaceuticals Raises $2.5M Through Direct Offering at $3.00 Per Share - StockTitan

Jan 15, 2025
pulisher
Jan 15, 2025

Phio Pharmaceuticals sharply lower on equity offering - MSN

Jan 15, 2025
pulisher
Jan 15, 2025

Stock market news: PTL -68.18%, Springview Holdings -41.63% among biggest losers during mid day trading - Business Upturn

Jan 15, 2025

Phio Pharmaceuticals Corp (PHIO) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Phio Pharmaceuticals Corp 주식 (PHIO) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Bitterman Robert J
President & CEO
Jun 06 '24
Buy
0.75
1,000
750
19,990
$66.10
price down icon 2.65%
$73.33
price down icon 0.15%
$31.60
price up icon 0.06%
$18.91
price down icon 11.53%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 7.93%
자본화:     |  볼륨(24시간):